Sildenafil for Treatment of Erectile Dysfunction in Men With Diabetes
Open Access
- 3 February 1999
- journal article
- clinical trial
- Published by American Medical Association (AMA) in JAMA
- Vol. 281 (5), 421-426
- https://doi.org/10.1001/jama.281.5.421
Abstract
Diabetes mellitus affects an estimated 15.7 million people in the United States, including 7.5 million men, with type 2, non–insulin-dependent, diabetes accounting for 90% to 95% of the diagnosed cases and type 1, insulin-dependent, diabetes accounting for 5% to 10%.1 A common complication of diabetes in men is erectile dysfunction (ED), defined by the National Institutes of Health Consensus Panel on Impotence as the persistent inability to attain and maintain an erection sufficient to permit satisfactory sexual activity.2Keywords
This publication has 8 references indexed in Scilit:
- Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic menDiabetic Medicine, 1998
- Oral Sildenafil in the Treatment of Erectile DysfunctionNew England Journal of Medicine, 1998
- Role of Nitric Oxide in the Physiology of Erection1Biology of Reproduction, 1995
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994
- Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscleBiochemical and Biophysical Research Communications, 1990
- Sexual dysfunction in the diabetic patient with hypertensionThe American Journal of Cardiology, 1988
- A Pragmatic Approach to Sexual Dysfunction in Diabetic Men: Psychosexual CounsellingDiabetic Medicine, 1986
- The prevalence of diabetic impotenceDiabetologia, 1980